2014 ACBD Publications

Conference Publication

Pinar, I., Arthur, J., Andrews, R., Gardiner, E., Ryan, K., Carberry, J., 2014, Techniques towards understanding shear dependent thrombus formation, Proceedings of the 19th Australasian Fluid Mechanics Conference, 08 December 2014 to 11 December 2014, RMIT University, Melbourne Vic Australia, pp. 1-4.

Journal Articles

Andrews, R.K., Arthur, J.F., Gardiner, E.E., 2014, Neutrophil extracellular traps (NETs) and the role of platelets in infection, Thrombosis and Haemostasis [P], vol 112, issue 4, Schattauer GmbH, Germany, pp. 659-665.

Andrews, R.K., Arthur, J.F., Gardiner, E.E., 2014, Targeting GPVI as a novel antithrombotic strategy, Journal of Blood Medicine, vol 2014, issue 5, Dove Medical Press, USA, pp. 59-68.

Andrews, R.K., Gardiner, E.E., 2014, Lymphomania, Blood [E], vol 123, issue 20, American Society of Hematology, Washington, DC 20036 United States, pp. 3057-3058.

Arumugaswamy, A., Tran, H.A., 2014, Post-thrombotic syndrome: A potential cause of venous ulcer, Wound Practice & Research [P], vol 22, issue 2, Cambridge Publishing, Australia, pp. 85-90.

Au, A.E., Sashindranath, M., Borg, R.J., Kleifeld, O., Andrews, R.K., Gardiner, E.E., Medcalf, R.L., Samson, A.L., 2014, Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase, Cell Death & Disease [E], vol 5, Nature Publishing Group, United Kingdom, pp. 1-13.

Benboubker, L., Dimopoulos, M.A., Dispenzieri, A., Catalano, J., Belch, A.R., Cavo, M.M., Pinto, A.I., Weisel, K.C., Ludwig, H., Bahlis, N.J., Banos, A., Tiab, M., Delforge, M., Cavenagh, J.D., Geraldes, C., Lee, J., Chen, C., Oriol, A., De La Rubia, J., Qiu, L., White, D.J., Binder, D., Anderson, K.C., Fermand, J., Moreau, P., Attal, M., Knight, R.D., Chen, G., Van Oostendorp, J., Jacques, C., Ervin-Haynes, A.L., Avet-Loiseau, H., Hulin, C., Facon, T., 2014, Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma, New England Journal Of Medicine [P], vol 371, issue 10, Massachusetts Medical Society, United States, pp. 906-917.

Berndt, M.C., Metharom, P., Andrews, R.K., 2014, Primary haemostasis: newer insights, Haemophilia [P], vol 20, issue S4, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 15-22.

Bilmon, I., Nivison-Smith, I., Hertzberg, M.S., Ritchie, D., Greenwood, M.J., Spencer, A., Kennedy, G.A., Bryant, A., Moore, J., 2014, Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning, Bone Marrow Transplantation [P], vol 49, issue 6, Nature Publishing Group, London, N1 9XW United Kingdom        Phone: 44-20-78334000, pp. 852-853.

Campbell, P., Walker, P.A., Avery, S., Curtis, D.J., Schwarer, A., Wei, A., Kalff, A., Muirhead, J.L., Spencer, A., 2014, Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma, Blood Cancer Journal [E], vol 4, issue 5, Macmillan Publishers Limited, London, N1 9XW United Kingdom, p. e213.

Cheah, C., Herbert, K., O'Rourke, K.M., Kennedy, G.A., George, A., Fedele, P.L., Gilbertson, M., Tan, S.Y., Ritchie, D., Opat, S., Prince, H.M., Dickinson, M.J., Burbury, K.L., Wolf, M., Januszewicz, E.H., Tam, C., Westerman, D.A., Carney, D., Harrison, S., Seymour, J.F., 2014, A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma, British Journal of Cancer [E], vol 111, issue 6, Nature Publishing Group, United Kingdom, pp. 1072-1079.

Crack, P.J., Zhang, M., Morganti-Kossmann, M.C., Morris, A., Wojciak, J.M., Fleming, J.K., Karve, I., Wright, D.K., Sashindranath, M., Goldshmit, Y., Conquest, A., Daglas, M., Johnston, L.A., Medcalf, R.L., Sabbadini, R.A., Pebay, A., 2014, Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes, Journal of Neuroinflammation [P], vol 11, issue (Art. No: 37), BioMed Central Ltd, United Kingdom, pp. 1-11.

Denecker, G., Vandamme, N., Akay, O., Koludrovic, D., Taminau, J., Lemeire, K., Gheldof, A., Craene, B.D., Van Gele, M., Brochez, L., Udupi, G., Rafferty, M., Balint, B., Gallagher, W.M., Ghanem, G., Huylebroeck, D., Haigh, J.J., van den Oord, J., Larue, L., Davidson, I., Marine, J., Berx, G., 2014, Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression, Cell Death and Differentiation [P], vol 21, issue 8, Nature Publishing Group, United Kingdom, pp. 1250-1261.

Fedele, P., Avery, S., Patil, S., Spencer, A., Haas, M., Wei, A., 2014, Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for acute myeloid leukaemia, Internal Medicine Journal [P], vol 44, issue 8, Wiley-Blackwell Publishing Asia, Australia, pp. 757-763.

Freeman, R., Niego, B., Croucher, D.R., Pederson, L.O., Medcalf, R.L., 2014, t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions, Brain Research [P], vol 1565, Elsevier BV, Netherlands, pp. 63-73.

Gardiner, E.E., Andrews, R.K., 2014, Plasma sGPVI: Changing levels in human disease, Thrombosis Research [P], vol 133, issue 3, Pergamon, Kidlington, Oxford OX5 1GB United Kingdom, pp. 306-307.

Gardiner, E.E., Andrews, R.K., 2014, Platelet receptor expression and shedding: Glycoprotein Ib-IX-V and glycoprotein VI, Transfusion Medicine Reviews [P], vol 28, issue 2, W.B. Saunders Co., Maryland Heights MO United States, pp. 56-60.

Gardiner, E.E., Andrews, R.K., 2014, Structure and function of platelet receptors initiating blood clotting, A Systems Biology Approach to Blood, vol 844, Springer, United States, pp. 263-275.

Gardiner, E.E., Andrews, R.K., Cuker, A.C., 2014, DiagnoSTic assays for heparin-induced thrombocytopenia, British Journal Of Haematology [P], vol 166, issue 5, Wiley-Blackwell Publishing Ltd., Chichester, West Sussex PO19 8QG United Kingdom, pp. 631-633.

Gardiner, E.E., Medcalf, R.L., 2014, Is plasminogen activator inhibitor type 2 really a plasminogen activator inhibitor after all?, Journal Of Thrombosis And Haemostasis [P], vol 12, issue 10, Wiley-Blackwell Publishing Ltd., Chichester, West Sussex PO19 8QG United Kingdom, pp. 1703-1705.

Gerby, B., Tremblay, C., Tremblay, M., Rojas-Sutterlin, S., Herblot, S., Hebert, J., Sauvageau, G., Lemieux, S., Lecuyer, E., Veiga, D.F.T., Trang, H., 2014, SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells, Plos Genetics [P], vol 10, issue 12 (Art. No.: e1004768), Public Library of Science, United States, pp. 1-19.

Gerondakis, S.D., Fulford, T., Messina, N.L., Grumont, R.J., 2014, NF-{kappa}B control of T cell development, Nature Immunology [P], vol 15, issue 1, Nature Publishing Group, United States, pp. 15-25.

Ghahremani, M.F., Radaelli, E., Haigh, K., Bartunkova, S., Haenebalcke, L., Marine, J., Goossens, S., Haigh, J.J., 2014, Loss of autocrine endothelial-derived VEGF significantly reduces hemangiosarcoma development in conditional p53-deficient mice, Cell Cycle [P], vol 13, issue 9, Landes Bioscience, United States, pp. 1501-1507.

Gitz, E., Pollitt, A.Y., Gitz-Francois, J.J., Alshehri, O., Mori, J., Montague, S., Nash, G.B., Douglas, M.R., Gardiner, E.E., Andrews, R.K., Buckley, C.D., Harrison, P., Watson, S.P., 2014, CLEC-2 expression is maintained on activated platelets and on platelet microparticles, Blood [P], vol 124, issue 14, American Society of Hematology, United States, pp. 2262-2270.

Goossens, S., Van Vlierberghe, P., 2014, Controlling Pre-leukemic Thymocyte Self-Renewal  (Article), Plos Genetics [P], vol 10, issue 12, Public Library of Science, United States, p. 1004881.

Govindaraj, C., Madondo, M., Kong, Y., Tan, P., Wei, A., Plebanski, M., 2014, Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients, American Journal Of Hematology [P], vol 89, issue 8, John Wiley & Sons, Inc., United States, pp. 795-802.

Govindaraj, C., Tan, P., Walker, P.A., Wei, A., Spencer, A., Plebanski, M., 2014, Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients, Clinical Cancer Research [P], vol 20, issue 3, American Association for Cancer Research, Philadelphia PA United States, pp. 724-735.

Hawkins, E., Oliaro, J., Ramsbottom, K.M., Ting, S.B.N., Sacirbegovic, F., Harvey, M., Kinwell, T., Ghysdael, J., Johnstone, R.W., Humbert, P.O., Russell, S.M., 2014, Lethal giant larvae 1 tumour suppressor activity is not conserved in models of mammalian T and B cell leukaemia, PLoS ONE [P], vol 9, issue 1 (Art. No.: e87376), Public Library of Science, United States, pp. 1-5.

Htun, K., McFadyen, J.D., Tran, H.A., 2014, The successful management of dabigatran-associated critical end-organ bleeding with recombinant factor VIIa, Annals Of Hematology [P], vol 93, issue 10, Springer, Heidelberg, 69121 Germany, pp. 1785-1786.

Huard, C.C., Tremblay, C., Magron, A., Levesque, G., Carreau, M., 2014, The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression, Proceedings Of The National Academy Of Sciences Of The United States Of America [P], vol 111, issue 6, National Academy of Sciences, USA, pp. 2152-2157.

Hughan, S.C., Spring, C.M., Schoenwaelder, S.M., Sturgeon, S.A., Alwis, I., Yuan, Y., McFadyen, J.D., Westein, E., Goddard, D.M., Ono, A., Yamanashi, Y., Nesbitt, W.S., Jackson, S., 2014, Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin aIIb{beta}3 in mice, Journal Of Biological Chemistry [P], vol 289, issue 8, American Society for Biochemistry and Molecular Biology, Inc., USA, pp. 5051-5060.

Iland, H.J., Seymour, J.F., Wei, A., 2014, Optimal approach for high-risk acute promyelocytic leukemia, Current Opinion In Hematology [P], vol 21, issue 2, Lippincott Williams & Wilkins, United States, pp. 102-113.

Iland, H.J., Wei, A., Seymour, J.F., 2014, Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care, Best Practice and Research in Clinical Haematology [P], vol 27, issue 1, Bailliere Tindall, United Kingdom, pp. 39-52.

Lamrani, L., Lacout, C., Ollivier, V., Denis, C.V., Gardiner, E.E., Ho Tin Noe, B., Vainchenker, W., Villeval, J., Jandrot-Perrus, M., 2014, Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm, Blood [P], vol 124, issue 7, American Society of Hematology, United States, pp. 1136-1145.

Lancaster, G.I., Kraakman, M.J., Kammoun, H.L., Langley, K.G., Estevez, E., Banerjee, A., Grumont, R.J., Febbraio, M.A., Gerondakis, S.D., 2014, The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice, PLoS ONE [E], vol 9, issue 11 (Art. ID: e111524), Public Library of Science, United States, pp. 1-8.

Liao, S., Woulfe, T., Hyder, S.W., Merriman, E.G., Simpson, D.E., Chunilal, S., 2014, Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study, Journal Of Thrombosis And Haemostasis [P], vol 12, issue 2, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 214-219.

Liu, H.B., Urbanavicius, D.B., Tan, P., Spencer, A., Dear, A.E., 2014, Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies, International Journal of Oncology [P], vol 45, issue 4, Spandidos Publications, Athens, 116 10 Greece, pp. 1742-1748.

Liu, H.B., Urbanavicius, D.B., Tan, P., Spencer, A., Dear, A.E., 2014, Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies, International Journal of Oncology [P], vol 45, issue 4, Spandidos Publications, Athens, 116 10 Greece, pp. 1742-1748.

Luo, L., Wall, A.A., Yeo, J.C., Condon, N.D., Norwood, S.J., Schoenwaelder, S.M., Chen, K.W., Jackson, S., Jenkins, B.J., Hartland, E.L., Schroder, K., Collins, B.M., Sweet, M.J., Stow, J.L., 2014, Rab8a interacts directly with PI3Kgamma to modulate TLR4-driven PI3K and mTOR signalling, Nature Communications [E], vol 5, issue (Art. No.:4407), Nature Publishing Group, United Kingdom, pp. 1-13.

Macesic, N., Morrissey, O., Cheng, A.C., Spencer, A., Peleg, A.Y., 2014, Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period, Transplant Infectious Disease [P], vol 16, issue 6, Wiley-Blackwell Publishin, Inc., United States, pp. 887-896.

Manchev, V.T., Hilpert, M., Berrou, E., Elaib, Z., Aouba, A., Boukour, S., Souguere, S., Gerard, P., Rameau, P., Andrews, R.K., Lanza, F., Bobe, R., Vainchenker, W.P., Rosa, J.P., Bryckaert, M.C., Debili, N., Favier, R., Raslova, H., 2014, A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene, Blood [P], vol 124, issue 16, American Society of Hematology, United States, pp. 2554-2563.

McFadyen, J.D., Butler, J.A., Malan, E., Tran, H.A., 2014, Causes and clinical significance of prolonged activated partial thromboplastin times in thalassaemia major, Annals of Hematology [E], vol 93, issue 5, Springer, Heidelberg, 69121 Germany, pp. 867-868.

McQuilten, Z., Wood, E.M., Polizzotto, M.N., Campbell, L., Wall, M., Curtis, D.J., Farrugia, H., McNeil, S.J., Sundararajan, V., 2014, Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study, Cancer [P], vol 120, issue 11, John Wiley & Sons, Inc., New Jersey, United States, pp. 1686-1694.

Mesa, R.A., Kiladjian, J.J., Verstovsek, S., Al-Ali, H.K., Gotlib, J.R., Gisslinger, H., Levy, R.S., Siulnik, A., Gupta, V., Khan, M., DiPersio, J.F., McQuitty, M., Catalano, J., Hunter, D.S., Knoops, L., Deininger, M.W.N., Cervantes, F., Miller, C.B., Vannucchi, A.M., Silver, R.T., Barbui, T., Talpaz, M., Barosi, G., Winton, E.F., Mendeson, E., Harvey, J.H., Arcasoy, M.O., Hexner, E.O., Lyons, R.M., Paquette, R.L., Raza, A., Sun, W., Sandor, V.A., Kantarjian, H.M., Harrison, C.N., 2014, Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies, Haematologica-The Hematology Journal [P], vol 99, issue 2, Fondazione Ferrata Storti, Italy, pp. 292-298.

Mithra Prabhu, S., Kalff, A., Chow, A., Khong, T.T.F., Spencer, A., 2014, Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma, Epigenetics [P], vol 9, issue 11, Taylor & Francis Inc., United States, pp. 1511-1520.

Mithra Prabhu, S., Khong, T.T.F., Spencer, A., 2014, Overcoming inherent resistance to histone deacetylase inhibitors in multiple myeloma cells by targeting pathways integral to the actin cytoskeleton, Cell Death & Disease [E], vol 5, issue 3 (Art. No.: e1134), Nature Publishing Group, United Kingdom, pp. 1-12.

Morrissey, O., Gilroy, N., Macesic, N., Walker, P.A., Ananda-Rajah, M.R., Heath, C.H., Grigg, A.P., Bardy, P., Kwan, J., Kirsa, S.W., Slavin, M.A., Gottlieb, T., 2014, Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014, Internal Medicine Journal [P], vol 44, issue 12, Wiley-Blackwell Publishing, pp. 1298-1314.

Niego, B., Medcalf, R.L., 2014, Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?, Journal of Cerebral Blood Flow and Metabolism [P], vol 34, issue 8, Nature Publishing Group, United States, pp. 1283-1296.

Palumbo, A., Bringhen, S., Kumar, S.K., Lupparelli, G., Usmani, S.Z., Waage, A., Larocca, A.T., Van Der Holt, B.R., Musto, P., Offidani, M., Petrucci, M.T., Evangelista, A., Zweegman, S., Nooka, A.K., Spencer, A., Dimopoulos, M.A., Hajek, R., Cavo, M.M., Richardson, P.G., Lonial, S., Ciccone, G., Boccadoro, M., Anderson, K.C., Barlogie, B.M., Sonneveld, P., McCarthy, P.L., 2014, Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data, Lancet Oncology [P], vol 15, issue 3, The Lancet Publishing Group, United Kingdom, pp. 333-342.

Pennings, G., Yong, A., Wong, C., Al-Tamimi, M., Gardiner, E.E., Andrews, R.K., Kritharides, L., 2014, Circulating levels of soluble EMMPRIN (CD147) correlate with levels of soluble glycoprotein VI in human plasma, Platelets [P], vol 25, issue 8, Informa Healthcare, United Kingdom, pp. 639-642.

Qiao, J.L., Shen, Y., Shi, M., Lu, Y., Cheng, J., Chen, Y., 2014, Molecular cloning and characterization of rhesus monkey platelet glycoprotein Ibalpha, a major ligand-binding subunit of GPIb-IX-V complex, Thrombosis Research [P], vol 133, issue 5, Pergamon Press, United Kingdom, pp. 817-825.

Rahmatzadeh, M., Liu, H.B., Krishna, S.M., Gaspari, T.A., Spizzo, I., Widdop, R.E., Dear, A.E., 2014, A novel agent with histone deacetylase inhibitory activity attenuates neointimal hyperplasia, Cardiovascular Drugs And Therapy [P], vol 28, issue 5, Springer New York LLC, United States, pp. 395-406.

Samson, A.L., Knaupp, A.S., Kass, I., Kleifeld, O., Marijanovic, E.M., Hughes, V.A., Lupton, C.J., Buckle, A.M., Bottomley, S.P., Medcalf, R.L., 2014, Oxidation of an exposed methionine instigates the aggregation of glyceraldehyde-3-phosphate dehydrogenase, Journal Of Biological Chemistry [P], vol 289, issue 39, American Society for Biochemistry and Molecular Biology Inc., USA, pp. 26922-26936.

San Miguel, J.F., Blade, J., Shpilberg, O., Grosicki, S., Maloisel, F., Min, C., Zarzuela, M.P., Robak, T., Prasad, S.V.S., Goh, Y., Laubach, J.P., Spencer, A., Mateos, M.V., Palumbo, A., Puchalski, T.A., Reddy, M.P., Uhlar, C.M., Qin, X., van de Velde, H., Xie, H., Orlowski, R.Z., 2014, Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma, Blood [E], vol 123, issue 26, American Society of Hematology, Washington, DC 20036 United States, pp. 4136-4142.

Seymour, J.F., Pfreundschuh, M.M., Trneny, M., Sehn, L., Catalano, J., Csinady, E., Moore, N., Coiffier, B.B., 2014, R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes, Haematologica-The Hematology Journal [P], vol 99, issue 8, Fondazione Ferrata Storti, Italy, pp. 1343-1349.

Shortt, J., Opat, S., Wood, E.M., 2014, N-Acetylcysteine for thrombotic thrombocytopenic purpura: Is a von Willebrand factor-inhibitory dose feasible in vivo?, Transfusion [P], vol 54, issue 9, Wiley-Blackwell Publishing, Inc., Hoboken, NJ 07030 United States, pp. 2362-2363.

Sidhu, T., French, S., Hamilton, J.R., 2014, Differential signaling by protease-activated receptors: implications for therapeutic targeting, International Journal of Molecular Sciences [P], vol 15, issue 4, M D P I AG, Switzerland, pp. 6169-6183.

Spencer, A., Yoon, S., Harrison, S., Morris, S.R., Smith, D.A., Brigandi, R.A., Gauvin, J.L.S., Kumar, R., Opalinska, J.B., Chen, C., 2014, The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma, Blood [P], vol 124, issue 14, American Society of Hematology, United States, pp. 2190-2195.

Tan, P., Wei, A., Mithra Prabhu, S., Cummings, N.J., Liu, H.B., Perugini, M., Reed, K.D., Avery, S., Patil, S., Walker, P.A., Mollee, P.N., Grigg, A.P., D'Andrea, R.J., Dear, A.E., Spencer, A., 2014, Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome, Blood Cancer Journal [E], vol 4, issue 1 (Art. No.: e170), Nature Publishing Group, United Kingdom, pp. 1-8.

Tan, P., Wei, A., Mithra Prabhu, S., Cummings, N.J., Liu, H.B., Perugini, M., Reed, K.D., Avery, S., Patil, S., Walker, P.A., Mollee, P.N., Grigg, A.P., D'Andrea, R.J., Dear, A.E., Spencer, A., 2014, Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome, Blood Cancer Journal [E], vol 4, issue 1 (Art. No.: e170), Nature Publishing Group, United Kingdom, pp. 1-8.

Tatari, M.N., De Craene, B.A., Soen, B., Taminau, J., Vermassen, P., Goossens, S., Haigh, K., Cazzola, S., Lambert, J., Huylebroeck, D., Haigh, J.J., Berx, G., 2014, ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteins, Cellular And Molecular Life Sciences [P], vol 71, issue 18, Springer Basel AG, Switzerland, pp. 3599-3609.

Tikellis, C., Brown, R., Head, G.A., Cooper, M.E., Thomas, M.C., 2014, Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes, American Journal of Physiology - Renal Fluid and Electrolyte Physiology [E], vol 306, issue 7, American Physiological Society, Bethesda MD United States, pp. F773-F780.

Tjarnlund Wolf, A., Hultman, K., Blomstrand, F., Nilsson, M., Medcalf, R.L., Jern, C., 2014, Species-specific regulation of t-PA and PAI-1 gene expression in human and rat astrocytes, Gene Regulation and Systems Biology [E], vol 2014, issue 8, Libertas Academica Ltd, Auckland New Zealand, pp. 113-118.

Tran, H.A., Brighton, T., Grigg, A.P., McRae, S., Dixon, J., Thurley, D., Gandhi, M.K., Truman, M., Marlton, P., Catalano, J., 2014, A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study), British Journal Of Haematology [P], vol 167, issue 2, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 243-251.

Tran, H.A., Chunilal, S., 2014, Prothrombin complex concentrate safely reverses warfarin-related bleeding, Evidence - Based Medicine (English Edition): for primary care and internal medicine [P], vol 19, issue 2, B M J Group, London, WC1H 9JR United Kingdom, p. 75.

Tran, H.A., Chunilal, S., Tran, H., 2014, RE: An update of consensus guidelines for warfarin reversal, Medical Journal Of Australia [P], vol 200, issue 2, Australasian Medical Publishing Company Pty. Ltd, strawberry Hills, NSW 2012 Australia, p. 82.

Tran, H.A., Chunilal, S., Tran, H., 2014, RE: An update of consensus guidelines for warfarin reversal, Medical Journal Of Australia [P], vol 200, issue 2, Australasian Medical Publishing Company Pty. Ltd, strawberry Hills, NSW 2012 Australia, p. 82.

Tran, H.A., Joseph, J.E., Young, L., McRae, S., Curnow, J., Nandurkar, H., Wood, P., McLintock, C.K., 2014, New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management, Internal Medicine Journal [P], vol 44, issue 6, Wiley-Blackwell Publishing Asia, Australia, pp. 525-536.

Tremblay, C., Curtis, D.J., 2014, The clonal evolution of leukemic stem cells in T-cell acute lymphoblastic leukemia, Current Opinion In Hematology [P], vol 21, issue 4, Lippincott Williams & Wilkins, United States, pp. 320-325.

Trist, H., Tan, P., Wines, B.D., Ramsland, P.A., Orlowski, E., Stubbs, J., Gardiner, E.E., Pietersz, G.A., Kent, S.J., Stratov, I., Burton, D., Hogarth, P.M., 2014, Polymorphisms and interspecies differences of the activating and inhibitory Fc{gamma}RII of Macaca nemestrina influence the binding of human IgG subclasses, Journal Of Immunology [P], vol 192, issue 2, American Association of Immunologists, USA, pp. 792-803.

Wang, X., Palasubramaniam, J., Gkanatsas, Y., Hohmann, J.D., Westein, E., Kanojia, R., Alt, K., Huang, D., Jia, F., Ahrens, I., Medcalf, R.L., Peter, K., Hagemeyer, C.E., 2014, Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets, Circulation Research [P], vol 114, issue 7, Lippincott Williams & Wilkins, Baltimore MD United States, pp. 1083-1093.

Wang, X., Palasubramaniam, J., Gkanatsas, Y., Hohmann, J.D., Westein, E., Kanojia, R., Alt, K., Huang, D., Jia, F., Ahrens, I., Medcalf, R.L., Peter, K., Hagemeyer, C.E., 2014, Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets, Circulation Research [P], vol 114, issue 7, Lippincott Williams & Wilkins, Baltimore MD United States, pp. 1083-1093.

Wei, A., Fleming, S.A., 2014, The role of HiDAC in AML - Author Reply, Internal Medicine Journal [E], vol 44, issue 8, Wiley-Blackwell Publishing Asia, Richmond, VIC 3121 Australia, p. 825.

Wenhao, N., Lim, J., Grumont, R.J., Gerondakis, S.D., I-Hsin, S., 2014, c-Rel regulates Ezh2 expression in activated lymphocytes and malignant lymphoid cells, Journal of Biological Chemistry [E], vol 289, issue 46, American Society for Biochemistry and Molecular Biology Inc., United States, pp. 31693-31707.